Unlock instant, AI-driven research and patent intelligence for your innovation.
Novel influenza virus A mammalian cell adapted strain and preparation and application thereof
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A type of influenza virus, host cell technology, applied in the field of biotechnology and immunology
Inactive Publication Date: 2016-10-05
INST PASTEUR OF SHANGHAI CHINESE ACADEMY OF SCI
View PDF4 Cites 6 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
However, PR8 is not suitable for amplification in mammalian cells, so it is necessary to develop new backbone strains for mammalian cell production platforms
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0162] Example 1. The NS gene derived from the WSN strain can promote the high-speed growth of the PR8 strain on Vero cells.
[0163] Vero cells are a mammalian cell line recommended by WHO for vaccine production, and their safety has been well proven. However, the backbone virus strain PR8 used in the production of influenza vaccines is an adaptation strain of chicken embryos, and the adaptation of the mammalian cell line Vero The performance is not good enough to meet the requirements of production.
[0164] Therefore, the inventors recombined the PR8 strain with other strains WSN that are more suitable for mammalian cell lines, and improved the adaptability of PR8 on Vero cells. The genes of PR8 strain (except HA and NA) were replaced with WSN by using reverse genetic technology. By comparing the size of the plaques, only the NS gene from WSN replaced the NS gene of PR8. Larger plaques were formed on cells than PR8 ( figure 1 A). And the recombinant virus PR8-WSN M (the ...
Embodiment 2
[0166] Example 2, NS2 K86R The mutation can promote the high-speed growth of PR8 on Vero.
[0167] In order to identify the site of NS gene that promotes the rapid growth of PR8 on Vero cells, the NS gene of PR8 strain was compared with the NS gene of WSN strain. The NS gene of PR8 and the NS gene of WSN shared 11 non-synonymous mutations in the nucleotide sequence, located at the 163,301,308,318,512,537,565,660,661,729,784 nucleotides ( figure 2 , A). Since the NS gene undergoes alternative splicing when it is transcribed into mRNA, two different mRNAs are formed, encoding the nonstructural protein NS1 and the nuclear export protein NS2 (NEP), respectively. These 11 nucleotide mutations resulted in 7 amino acid mutations on the NS1 protein and 6 amino acid mutations on the NS2 protein ( figure 2 , A).
[0168] With the method of reverse genetics, the PR8-based strains with all the above-mentioned NS gene non-synonymous mutations were rescued (103F and 106M are known to st...
Embodiment 3
[0170] Embodiment 3, NS2 K86R The mutation does not change the antigenicity of PR8, as well as the pathogenicity to mice and chicken embryos.
[0171] In mammalian cell culturesystem, PR8 high-producing strain (PR8-NS2 K86R ) has a faster growth rate than the PR8 wild-type virus, and the inventors need to measure whether its pathogenicity to mammals and birds is also increased accordingly, which is of great significance to the safe production of vaccines.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
PUM
Login to View More
Abstract
The invention discloses a novel influenza virus A mammalian cell adapted strain and preparation and application thereof and particularly provides PR8 virus strain mutantprotein and a recombinant PR8 virus strain containing the PR8 virus strainmutantprotein, wherein the PR8 virus strainmutantprotein can greatly improve the growing ability of an influenza virus A strain PR8 on mammalian cells (particularly Vero cells), after K at the site 86 of NS2 protein of the PR8 virus strain is mutated into R, the growing ability of the obtained virus strain on the Vero cells is improved by 20-100 times compared with that of a wild PR8 virus strain, and the pathogenicity of the adapted strain on a living body is not enhanced. Therefore, the influenza virus A strain containing the mutant protein can serve as a high-yield vaccine seed strain on mammalian cells.
Description
technical field [0001] The invention belongs to the fields of biotechnology and immunology; more specifically, the invention relates to a method for obtaining a mammalian cell-adapted strain of influenza Avirus vaccine and an adapted site. Background technique [0002] Influenza is one of the most serious infectious diseases in human history, and its main pathogen is influenza virus. Its host range is broad, including wild birds, poultry, various mammals, and humans. It mutates quickly and can change its antigenicity to evade host immune systemattack, or change its own drug target characteristics to gaindrug resistance. These characteristics determine that influenza virus can spread widely among humans and animals and is difficult to control. In addition to causing seasonal epidemics (epidemic) every year, it also causes pandemics (pandemic) from time to time, which brings huge losses to human society. In the past century, influenza viruses have had four major pandemic...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.